Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,707 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Free HIV self-test for identification and linkage to care of previously undetected HIV infection in men who have sex with men in England and Wales (SELPHI): an open-label, internet-based, randomised controlled trial.
Rodger AJ, McCabe L, Phillips AN, Lampe FC, Burns F, Ward D, Delpech V, Weatherburn P, Witzel TC, Pebody R, Kirwan P, Gabriel M, Khawam J, Brady M, Fenton KA, Trevelion R, Collaco-Moraes Y, McCormack S, Dunn D. Rodger AJ, et al. Among authors: dunn d. Lancet HIV. 2022 Dec;9(12):e838-e847. doi: 10.1016/S2352-3018(22)00266-1. Lancet HIV. 2022. PMID: 36460023 Free PMC article. Clinical Trial.
A randomized controlled trial of the value of phenotypic testing in addition to genotypic testing for HIV drug resistance: evaluation of resistance assays (ERA) trial investigators.
Dunn DT, Green H, Loveday C, Rinehart A, Pillay D, Fisher M, McCormack S, Babiker AG, Darbyshire JH; Evaluation of Resistance Assays (ERA) Trial Investigators. Dunn DT, et al. J Acquir Immune Defic Syndr. 2005 Apr 15;38(5):553-9. doi: 10.1097/01.qai.0000148533.12329.96. J Acquir Immune Defic Syndr. 2005. PMID: 15793365 Clinical Trial.
What is the risk of mortality following diagnosis of multidrug-resistant HIV-1?
Grover D, Copas A, Green H, Edwards SG, Dunn DT, Sabin C, Phillips A, Allen E, Pillay D; UK Collaborative Group on HIV Drug Resistance and UK Collaborative HIV Cohort Study (UK CHIC). Grover D, et al. Among authors: dunn dt. J Antimicrob Chemother. 2008 Mar;61(3):705-13. doi: 10.1093/jac/dkm522. Epub 2008 Jan 25. J Antimicrob Chemother. 2008. PMID: 18222956
Factors influencing lopinavir and atazanavir plasma concentration.
Stöhr W, Back D, Dunn D, Sabin C, Winston A, Gilson R, Pillay D, Hill T, Ainsworth J, Gazzard B, Leen C, Bansi L, Fisher M, Orkin C, Anderson J, Johnson M, Easterbrook P, Gibbons S, Khoo S; UK CHIC Steering Committee. Stöhr W, et al. Among authors: dunn d. J Antimicrob Chemother. 2010 Jan;65(1):129-37. doi: 10.1093/jac/dkp408. J Antimicrob Chemother. 2010. PMID: 19897506 Free PMC article.
Data linkage reduces loss to follow-up in an observational HIV cohort study.
Hill T, Bansi L, Sabin C, Phillips A, Dunn D, Anderson J, Easterbrook P, Fisher M, Gazzard B, Gilson R, Johnson M, Leen C, Orkin C, Schwenk A, Walsh J, Winston A, Babiker A, Delpech V; UK Collaborative HIV Cohort Study Group. Hill T, et al. Among authors: dunn d. J Clin Epidemiol. 2010 Oct;63(10):1101-9. doi: 10.1016/j.jclinepi.2009.12.007. Epub 2010 Mar 29. J Clin Epidemiol. 2010. PMID: 20347263
The effect of transmitted HIV-1 drug resistance on pre-therapy viral load.
Harrison L, Castro H, Cane P, Pillay D, Booth C, Phillips A, Geretti AM, Dunn D; UK Collaborative Group on HIV Drug Resistance and the UK Collaborative HIV Cohort Study (UK CHIC). Harrison L, et al. Among authors: dunn d. AIDS. 2010 Jul 31;24(12):1917-22. doi: 10.1097/QAD.0b013e32833c1d93. AIDS. 2010. PMID: 20588166
Outcomes in the first year after initiation of first-line HAART among heterosexual men and women in the UK CHIC Study.
Barber TJ, Geretti AM, Anderson J, Schwenk A, Phillips AN, Bansi L, Gilson R, Hill T, Walsh J, Fisher M, Johnson M, Post F, Easterbrook P, Gazzard B, Palfreeman A, Orkin C, Leen C, Gompels M, Dunn D, Delpech V, Pillay D, Sabin CA; UK CHIC Study Steering Committee. Barber TJ, et al. Among authors: dunn d. Antivir Ther. 2011;16(6):805-14. doi: 10.3851/IMP1818. Antivir Ther. 2011. PMID: 21900712
Frequency and patterns of protease gene resistance mutations in HIV-infected patients treated with lopinavir/ritonavir as their first protease inhibitor.
Barber TJ, Harrison L, Asboe D, Williams I, Kirk S, Gilson R, Bansi L, Pillay D, Dunn D; UK HIV Drug Resistance Database and UK Collaborative HIV Cohort (UK CHIC) Study Steering Committees. Barber TJ, et al. Among authors: dunn d. J Antimicrob Chemother. 2012 Apr;67(4):995-1000. doi: 10.1093/jac/dkr569. Epub 2012 Jan 17. J Antimicrob Chemother. 2012. PMID: 22258921
1,707 results